Flu Vaccines Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032
- Report ID: ME_0083414
- Format: Electronic (PDF)
- Publish Type:
- Number of Pages: 250
Market Snapshot
CAGR:8.81
Source: Market Expertz
| Study Period | 2019-2032 |
| Base Year | 2023 |
| Forcast Year | 2023-2032 |
| CAGR | 8.81 |
Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries
Download Sample PdfReport Overview
In this report, EMEA Flu Vaccine Market will reach 1185.08 Million USD by the end of 2022 with a CAGR of 7.94%The EMEA Flu Vaccine market was valued at 808.63 Million USD in 2017 and will reach 1185.08 Million USD by the end of 2022, growing at a CAGR of 7.94% during 2017-2022.
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Flu Vaccine can be divided into four categories: Whole Virus Vaccines type, Split Virus Vaccines type, Subunit Vaccines type and Live Attenuated Virus Vaccines type. Whole Virus Vaccines type accounted for the highest proportion in sales market, with a figure of 43.15% in 2017, followed by Subunit Vaccines, account for 19.57% and Split Virus Vaccines type accounted for 18.93%.
The sales market share of EMEA Flu Vaccine in For Children (6 months to 3 years) use and For Adults and Children over 3 years use has been stable year by year, at 23.21% and 76.79% respectively in 2017, and for several consecutive years, the amplitude was within one percent. This indicates that the segment of the Flu Vaccine in the EMEA market tends to be fixed without great changes. Among them, the Flu Vaccine market has the most promising sales prospects in For Adults and Children over 3years use.
Our data shows that Europe is the biggest contributor to the Flu Vaccine revenue market, accounted for 81.08% of the total EMEA market with a revenue of 655.61 million USD in 2017, followed by Middle East, 11.75% with a revenue of 94.99 million USD.
Market competition is not intense. CSL, GSK, Sanofi Pasteur, Mylan, AstraZeneca, Pfizer and Johnson & Johnson, etc. are the leaders of the industry in the EMEA, with high-end customers in the Flu Vaccine market.
Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Flu Vaccine for these regions, from 2014 to 2026 (forecast), including
Germany
UK
France
Russia
Benelux
Italy
Spain
Europe Flu Vaccine market competition by top manufacturers/players, with Flu Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
...
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Flu Vaccine for each application, including
For Children (6 months to 3 years)
For Adults and Children over 3 years
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Flu Vaccine Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Whole Virus Vaccines Market Performance (Volume)
2.1.2 Split Virus Vaccines Market Performance (Volume)
2.1.3 Subunit Vaccines Market Performance (Volume)
2.1.4 Live Attenuated Virus Vaccines Market Performance (Volume)
2.2 Overall Market Performance(Value)
2.2.1 Whole Virus Vaccines Market Performance (Value)
2.2.2 Split Virus Vaccines Market Performance (Value)
2.2.3 Subunit Vaccines Market Performance (Value)
2.2.4 Live Attenuated Virus Vaccines Market Performance (Value)
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 For Children (6 months to 3 years) Market Performance (Volume)
3.1.2 For Adults and Children over 3 years Market Performance (Volume)
4 Manufacturers Profiles/Analysis
4.1 CSL
4.1.1 CSL Profiles
4.1.2 CSL Product Information
4.1.3 CSL Flu Vaccine Business Performance
4.1.4 CSL Flu Vaccine Business Development and Market Status
4.2 GSK
4.2.1 GSK Profiles
4.2.2 GSK Product Information
4.2.3 GSK Flu Vaccine Business Performance
4.2.4 GSK Flu Vaccine Business Development and Market Status
4.3 Sanofi Pasteur
4.3.1 Sanofi Pasteur Profiles
4.3.2 Sanofi Pasteur Product Information
4.3.3 Sanofi Pasteur Flu Vaccine Business Performance
4.3.4 Sanofi Pasteur Flu Vaccine Business Development and Market Status
4.4 Mylan
4.4.1 Mylan Profiles
4.4.2 Mylan Product Information
4.4.3 Mylan Flu Vaccine Business Performance
4.4.4 Mylan Flu Vaccine Business Development and Market Status
4.5 AstraZeneca
4.5.1 AstraZeneca Profiles
4.5.2 AstraZeneca Product Information
4.5.3 AstraZeneca Flu Vaccine Business Performance
4.5.4 AstraZeneca Flu Vaccine Business Development and Market Status
4.6 Pfizer
4.6.1 Pfizer Profiles
4.6.2 Pfizer Product Information
4.6.3 Pfizer Flu Vaccine Business Performance
4.6.4 Pfizer Flu Vaccine Business Development and Market Status
4.7 Johnson & Johnson
4.7.1 Johnson & Johnson Profiles
4.7.2 Johnson & Johnson Product Information
4.7.3 Johnson & Johnson Flu Vaccine Business Performance
4.7.4 Johnson & Johnson Flu Vaccine Business Development and Market Status
5 Market Performance for Manufacturers
5.1 Europe Flu Vaccine Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Europe Flu Vaccine Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Europe Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
5.4 Europe Flu Vaccine Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 Germany Market Performance for Manufacturers
6.1.1 Germany Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 Germany Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 Germany Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 Germany Flu Vaccine Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 UK Market Performance for Manufacturers
6.2.1 UK Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 UK Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 UK Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 UK Flu Vaccine Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 France Market Performance for Manufacturers
6.3.1 France Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 France Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 France Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 France Flu Vaccine Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Russia Market Performance for Manufacturers
6.4.1 Russia Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Russia Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Russia Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Russia Flu Vaccine Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Benelux Market Performance for Manufacturers
6.5.1 Benelux Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Benelux Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Benelux Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Benelux Flu Vaccine Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 Italy Market Performance for Manufacturers
6.6.1 Italy Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 Italy Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 Italy Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 Italy Flu Vaccine Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Spain Market Performance for Manufacturers
6.7.1 Spain Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Spain Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Spain Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Spain Flu Vaccine Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 Market Performance for Manufacturers
6.8.1 Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 Flu Vaccine Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Europe Flu Vaccine Market Performance (Sales Point)
7.1 Europe Flu Vaccine Sales (K Units) and Market Share by Regions 2014-2020
7.2 Europe Flu Vaccine Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Europe Flu Vaccine Price (USD/Unit) by Regions 2014-2020
7.4 Europe Flu Vaccine Gross Margin by Regions 2014-2020
8 Development Trend for Regions (Sales Point)
8.1 Europe Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
8.2 Germany Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
8.3 UK Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 France Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
8.5 Russia Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
8.6 Benelux Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
8.7 Italy Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
8.8 Spain Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 For Children (6 months to 3 years) Industry
11.2 For Adults and Children over 3 years Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Europe Flu Vaccine Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Europe Flu Vaccine Sales (K Units) and Growth Rate 2021-2026
12.1.3 Germany Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 UK Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 France Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Russia Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Benelux Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 Italy Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Spain Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Whole Virus Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.3 Split Virus Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.4 Subunit Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.5 Live Attenuated Virus Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.3 Sales Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 For Children (6 months to 3 years) Sales and and Growth Rate 2021-2026
12.3.3 For Adults and Children over 3 years Sales and and Growth Rate 2021-2026
12.4 Price (USD/Unit) and Gross Profit Forecast
12.4.1 Europe Flu Vaccine Price (USD/Unit) Trend 2021-2026
12.4.2 Europe Flu Vaccine Gross Profit Trend 2021-2026
13 Conclusion
List of Tables and Figures
Figure Product Picture of Flu Vaccine
Table Product Specifications of Flu Vaccine
Table Manufacturers List in the Report
Table Manufacturers Production Market Share (%) 2014-2020
Table Regions Overview in 2019
Table Product Type and Standard
Table Type Overview in 2019
Table Product Application and Standard
Table Application Overview in 2019
Figure Industry Chain Structure of Flu Vaccine
Table Industry News List of Flu Vaccine
Figure New Project SWOT Analysis of Flu Vaccine
Table Europe Flu Vaccine Sales (K Units) by Types
Figure Europe Flu Vaccine Sales Market Share (%) by Types in 2014
Figure Europe Flu Vaccine Sales Market Share (%) by Types in 2019
Table Whole Virus Vaccines Sales (K Units) and Growth Rate
Figure Whole Virus Vaccines Sales (K Units) and Growth Rate
Table Split Virus Vaccines Sales (K Units) and Growth Rate
Figure Split Virus Vaccines Sales (K Units) and Growth Rate
Table Subunit Vaccines Sales (K Units) and Growth Rate
Figure Subunit Vaccines Sales (K Units) and Growth Rate
Table Live Attenuated Virus Vaccines Sales (K Units) and Growth Rate
Figure Live Attenuated Virus Vaccines Sales (K Units) and Growth Rate
Table Europe Flu Vaccine Revenue (M USD) by Types
Figure Europe Flu Vaccine Revenue Market Share (%) by Types in 2014
Figure Europe Flu Vaccine Revenue Market Share (%) by Types in 2019
Table Whole Virus Vaccines Revenue (M USD) and Growth Rate
Figure Whole Virus Vaccines Revenue (M USD) and Growth Rate
Table Split Virus Vaccines Revenue (M USD) and Growth Rate
Figure Split Virus Vaccines Revenue (M USD) and Growth Rate
Table Subunit Vaccines Revenue (M USD) and Growth Rate
Figure Subunit Vaccines Revenue (M USD) and Growth Rate
Table Live Attenuated Virus Vaccines Revenue (M USD) and Growth Rate
Figure Live Attenuated Virus Vaccines Revenue (M USD) and Growth Rate
Table Europe Flu Vaccine Sales (K Units) by Application 2014-2020
Figure Europe Flu Vaccine Sales Market Share (%) by Application in 2014
Figure Europe Flu Vaccine Sales Market Share (%) by Application in 2019
Table For Children (6 months to 3 years) Sales (K Units) and Growth Rate 2014-2020
Figure For Children (6 months to 3 years) Sales (K Units) and Growth Rate 2014-2020
Table For Adults and Children over 3 years Sales (K Units) and Growth Rate 2014-2020
Figure For Adults and Children over 3 years Sales (K Units) and Growth Rate 2014-2020
Table CSL Profiles
Table CSL Product Information
Table CSL Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table CSL Flu Vaccine Sales Change 2014-2020
Table CSL Flu Vaccine Market Status Change 2014-2020
Table GSK Profiles
Table GSK Product Information
Table GSK Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table GSK Flu Vaccine Sales Change 2014-2020
Table GSK Flu Vaccine Market Status Change 2014-2020
Table Sanofi Pasteur Profiles
Table Sanofi Pasteur Product Information
Table Sanofi Pasteur Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Sanofi Pasteur Flu Vaccine Sales Change 2014-2020
Table Sanofi Pasteur Flu Vaccine Market Status Change 2014-2020
Table Mylan Profiles
Table Mylan Product Information
Table Mylan Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Mylan Flu Vaccine Sales Change 2014-2020
Table Mylan Flu Vaccine Market Status Change 2014-2020
Table AstraZeneca Profiles
Table AstraZeneca Product Information
Table AstraZeneca Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table AstraZeneca Flu Vaccine Sales Change 2014-2020
Table AstraZeneca Flu Vaccine Market Status Change 2014-2020
Table Pfizer Profiles
Table Pfizer Product Information
Table Pfizer Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Pfizer Flu Vaccine Sales Change 2014-2020
Table Pfizer Flu Vaccine Market Status Change 2014-2020
Table Johnson & Johnson Profiles
Table Johnson & Johnson Product Information
Table Johnson & Johnson Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Johnson & Johnson Flu Vaccine Sales Change 2014-2020
Table Johnson & Johnson Flu Vaccine Market Status Change 2014-2020
Table Europe Flu Vaccine Sales (K Units) of Manufacturers 2014-2020
Table Europe Flu Vaccine Sales Market Share (%) of Manufacturers 2014-2020
Figure Europe Flu Vaccine Sales Market Share (%) in 2014
Figure Europe Flu Vaccine Sales Market Share (%) in 2019
Table Europe Flu Vaccine Revenue (M USD) of Manufacturers 2014-2020
Table Europe Flu Vaccine Revenue Market Share (%) of Manufacturers 2014-2020
Figure Europe Flu Vaccine Revenue Market Share (%) in 2014
Figure Europe Flu Vaccine Revenue Market Share (%) in 2019
Table Europe Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
Figure Europe Flu Vaccine Price (USD/Unit) of Manufacturers in 2014
Figure Europe Flu Vaccine Price (USD/Unit) of Manufacturers in 2019
Table Europe Flu Vaccine Gross Margin of Manufacturers 2014-2020
Figure Europe Flu Vaccine Gross Margin of Manufacturers in 2014
Figure Europe Flu Vaccine Gross Margin in 2019
Figure Europe Flu Vaccine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table UK Flu Vaccine Sales (K Units) of Manufacturers 2014-2020
Table UK Flu Vaccine Sales Market Share (%) of Manufacturers 2014-2020
Figure UK Flu Vaccine Sales Market Share (%) in 2014
Figure UK Flu Vaccine Sales Market Share (%) in 2019
Table UK Flu Vaccine Revenue (M USD) of Manufacturers 2014-2020
Table UK Flu Vaccine Revenue Market Share (%) of Manufacturers 2014-2020
Figure UK Flu Vaccine Revenue Market Share (%) in 2014
Figure UK Flu Vaccine Revenue Market Share (%) in 2019
Table UK Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
Figure UK Flu Vaccine Price (USD/Unit) of Manufacturers in 2014
Figure UK Flu Vaccine Price (USD/Unit) of Manufacturers in 2019
Table UK Flu Vaccine Gross Margin of Manufacturers 2014-2020
Figure UK Flu Vaccine Gross Margin of Manufacturers in 2014
Figure UK Flu Vaccine Gross Margin in 2019
Figure UK Flu Vaccine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table France Flu Vaccine Sales (K Units) of Manufacturers 2014-2020
Table France Flu Vaccine Sales Market Share (%) of Manufacturers 2014-2020
Figure France Flu Vaccine Sales Market Share (%) in 2014
Figure France Flu Vaccine Sales Market Share (%) in 2019
Table France Flu Vaccine Revenue (M USD) of Manufacturers 2014-2020
Table France Flu Vaccine Revenue Market Share (%) of Manufacturers 2014-2020
Figure France Flu Vaccine Revenue Market Share (%) in 2014
Figure France Flu Vaccine Revenue Market Share (%) in 2019
Table France Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
Figure France Flu Vaccine Price (USD/Unit) of Manufacturers in 2014
Figure France Flu Vaccine Price (USD/Unit) of Manufacturers in 2019
Table France Flu Vaccine Gross Margin of Manufacturers 2014-2020
Figure France Flu Vaccine Gross Margin of Manufacturers in 2014
Figure France Flu Vaccine Gross Margin in 2019
Figure France Flu Vaccine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Russia Flu Vaccine Sales (K Units) of Manufacturers 2014-2020
Table Russia Flu Vaccine Sales Market Share (%) of Manufacturers 2014-2020
Figure Russia Flu Vaccine Sales Market Share (%) in 2014
Figure Russia Flu Vaccine Sales Market Share (%) in 2019
Table Russia Flu Vaccine Revenue (M USD) of Manufacturers 2014-2020
Table Russia Flu Vaccine Revenue Market Share (%) of Manufacturers 2014-2020
Figure Russia Flu Vaccine Revenue Market Share (%) in 2014
Figure Russia Flu Vaccine Revenue Market Share (%) in 2019
Table Russia Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
Figure Russia Flu Vaccine Price (USD/Unit) of Manufacturers in 2014
Figure Russia Flu Vaccine Price (USD/Unit) of Manufacturers in 2019
Table Russia Flu Vaccine Gross Margin of Manufacturers 2014-2020
Figure Russia Flu Vaccine Gross Margin of Manufacturers in 2014
Figure Russia Flu Vaccine Gross Margin in 2019
Figure Russia Flu Vaccine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Benelux Flu Vaccine Sales (K Units) of Manufacturers 2014-2020
Table Benelux Flu Vaccine Sales Market Share (%) of Manufacturers 2014-2020
Figure Benelux Flu Vaccine Sales Market Share (%) in 2014
Figure Benelux Flu Vaccine Sales Market Share (%) in 2019
Table Benelux Flu Vaccine Revenue (M USD) of Manufacturers 2014-2020
Table Benelux Flu Vaccine Revenue Market Share (%) of Manufacturers 2014-2020
Figure Benelux Flu Vaccine Revenue Market Share (%) in 2014
Figure Benelux Flu Vaccine Revenue Market Share (%) in 2019
Table Benelux Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
Figure Benelux Flu Vaccine Price (USD/Unit) of Manufacturers in 2014
Figure Benelux Flu Vaccine Price (USD/Unit) of Manufacturers in 2019
Table Benelux Flu Vaccine Gross Margin of Manufacturers 2014-2020
Figure Benelux Flu Vaccine Gross Margin of Manufacturers in 2014
Figure Benelux Flu Vaccine Gross Margin in 2019
Figure Benelux Flu Vaccine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Italy Flu Vaccine Sales (K Units) of Manufacturers 2014-2020
Table Italy Flu Vaccine Sales Market Share (%) of Manufacturers 2014-2020
Figure Italy Flu Vaccine Sales Market Share (%) in 2014
Figure Italy Flu Vaccine Sales Market Share (%) in 2019
Table Italy Flu Vaccine Revenue (M USD) of Manufacturers 2014-2020
Table Italy Flu Vaccine Revenue Market Share (%) of Manufacturers 2014-2020
Figure Italy Flu Vaccine Revenue Market Share (%) in 2014
Figure Italy Flu Vaccine Revenue Market Share (%) in 2019
Table Italy Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
Figure Italy Flu Vaccine Price (USD/Unit) of Manufacturers in 2014
Figure Italy Flu Vaccine Price (USD/Unit) of Manufacturers in 2019
Table Italy Flu Vaccine Gross Margin of Manufacturers 2014-2020
Figure Italy Flu Vaccine Gross Margin of Manufacturers in 2014
Figure Italy Flu Vaccine Gross Margin in 2019
Figure Italy Flu Vaccine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Spain Flu Vaccine Sales (K Units) of Manufacturers 2014-2020
Table Spain Flu Vaccine Sales Market Share (%) of Manufacturers 2014-2020
Figure Spain Flu Vaccine Sales Market Share (%) in 2014
Figure Spain Flu Vaccine Sales Market Share (%) in 2019
Table Spain Flu Vaccine Revenue (M USD) of Manufacturers 2014-2020
Table Spain Flu Vaccine Revenue Market Share (%) of Manufacturers 2014-2020
Figure Spain Flu Vaccine Revenue Market Share (%) in 2014
Figure Spain Flu Vaccine Revenue Market Share (%) in 2019
Table Spain Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
Figure Spain Flu Vaccine Price (USD/Unit) of Manufacturers in 2014
Figure Spain Flu Vaccine Price (USD/Unit) of Manufacturers in 2019
Table Spain Flu Vaccine Gross Margin of Manufacturers 2014-2020
Figure Spain Flu Vaccine Gross Margin of Manufacturers in 2014
Figure Spain Flu Vaccine Gross Margin in 2019
Figure Spain Flu Vaccine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Flu Vaccine Sales (K Units) of Manufacturers 2014-2020
Table Flu Vaccine Sales Market Share (%) of Manufacturers 2014-2020
Figure Flu Vaccine Sales Market Share (%) in 2014
Figure Flu Vaccine Sales Market Share (%) in 2019
Table Flu Vaccine Revenue (M USD) of Manufacturers 2014-2020
Table Flu Vaccine Revenue Market Share (%) of Manufacturers 2014-2020
Figure Flu Vaccine Revenue Market Share (%) in 2014
Figure Flu Vaccine Revenue Market Share (%) in 2019
Table Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
Figure Flu Vaccine Price (USD/Unit) of Manufacturers in 2014
Figure Flu Vaccine Price (USD/Unit) of Manufacturers in 2019
Table Flu Vaccine Gross Margin of Manufacturers 2014-2020
Figure Flu Vaccine Gross Margin of Manufacturers in 2014
Figure Flu Vaccine Gross Margin in 2019
Figure Flu Vaccine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Europe Flu Vaccine Sales (K Units) by Regions 2014-2020
Table Europe Flu Vaccine Sales Market Share (%) by Regions 2014-2020
Figure Europe Flu Vaccine Sales Market Share (%) by Regions in 2014
Figure Europe Flu Vaccine Sales Market Share (%) by Regions in 2019
Table Europe Flu Vaccine Revenue (M USD) by Regions 2014-2020
Table Europe Flu Vaccine Revenue Market Share (%) by Regions 2014-2020
Figure Europe Flu Vaccine Revenue Market Share (%) by Regions in 2014
Figure Europe Flu Vaccine Revenue Market Share (%) by Regions in 2019
Table Europe Flu Vaccine Price (USD/Unit) by Regions 2014-2020
Figure Europe Flu Vaccine Price (USD/Unit) by Regions in 2014
Figure Europe Flu Vaccine Price (USD/Unit) by Regions in 2019
Table Europe Flu Vaccine Gross Margin by Regions 2014-2020
Figure Europe Flu Vaccine Gross Margin by Regions in 2014
Figure Europe Flu Vaccine Gross Margin by Regions in 2019
Figure Europe Flu Vaccine Sales (K Units) and Growth Rate 2014-2020
Figure Europe Flu Vaccine Revenue (M USD) and Growth Rate 2014-2020
Figure Germany Flu Vaccine Sales (K Units) and Growth Rate 2014-2020
Figure Germany Flu Vaccine Revenue (M USD) and Growth Rate 2014-2020
Figure UK Flu Vaccine Sales (K Units) and Growth Rate 2014-2020
Figure UK Flu Vaccine Revenue (M USD) and Growth Rate 2014-2020
Figure France Flu Vaccine Sales (K Units) and Growth Rate 2014-2020
Figure France Flu Vaccine Revenue (M USD) and Growth Rate 2014-2020
Figure Russia Flu Vaccine Sales (K Units) and Growth Rate 2014-2020
Figure Russia Flu Vaccine Revenue (M USD) and Growth Rate 2014-2020
Figure Benelux Flu Vaccine Sales (K Units) and Growth Rate 2014-2020
Figure Benelux Flu Vaccine Revenue (M USD) and Growth Rate 2014-2020
Figure Italy Flu Vaccine Sales (K Units) and Growth Rate 2014-2020
Figure Italy Flu Vaccine Revenue (M USD) and Growth Rate 2014-2020
Figure Spain Flu Vaccine Sales (K Units) and Growth Rate 2014-2020
Figure Spain Flu Vaccine Revenue (M USD) and Growth Rate 2014-2020
Figure Flu Vaccine Sales (K Units) and Growth Rate 2014-2020
Figure Flu Vaccine Revenue (M USD) and Growth Rate 2014-2020
Table Upstream Source for Manufacturers
Table Manufacture Technology of Flu Vaccine
Figure Cost Structure of Flu Vaccine in 2019
Table Europe Flu Vaccine Production (K Units) by Regions 2021-2026
Table Europe Flu Vaccine Production Market Share (%) by Regions 2021-2026
Figure Europe Flu Vaccine Production Market Share (%) by Regions in 2019
Figure Europe Flu Vaccine Production Market Share (%) by Regions in 2024
Table Europe Flu Vaccine Revenue (M USD) by Regions 2021-2026
Table Europe Flu Vaccine Revenue Market Share (%) by Regions 2021-2026
Figure Europe Flu Vaccine Revenue Market Share (%) by Regions in 2019
Figure Europe Flu Vaccine Revenue Market Share (%) by Regions in 2024
Figure Europe Flu Vaccine Production (K Units) and Growth Rate 2021-2026
Figure Europe Flu Vaccine Revenue (M USD) and Growth Rate 2021-2026
Figure Germany Flu Vaccine Production (K Units) and Growth Rate 2021-2026
Figure Germany Flu Vaccine Revenue (M USD) and Growth Rate 2021-2026
Figure UK Flu Vaccine Production (K Units) and Growth Rate 2021-2026
Figure UK Flu Vaccine Revenue (M USD) and Growth Rate 2021-2026
Figure France Flu Vaccine Production (K Units) and Growth Rate 2021-2026
Figure France Flu Vaccine Revenue (M USD) and Growth Rate 2021-2026
Figure Russia Flu Vaccine Production (K Units) and Growth Rate 2021-2026
Figure Russia Flu Vaccine Revenue (M USD) and Growth Rate 2021-2026
Figure Benelux Flu Vaccine Production (K Units) and Growth Rate 2021-2026
Figure Benelux Flu Vaccine Revenue (M USD) and Growth Rate 2021-2026
Figure Italy Flu Vaccine Production (K Units) and Growth Rate 2021-2026
Figure Italy Flu Vaccine Revenue (M USD) and Growth Rate 2021-2026
Figure Spain Flu Vaccine Production (K Units) and Growth Rate 2021-2026
Figure Spain Flu Vaccine Revenue (M USD) and Growth Rate 2021-2026
Figure Flu Vaccine Production (K Units) and Growth Rate 2021-2026
Figure Flu Vaccine Revenue (M USD) and Growth Rate 2021-2026
Table Europe Flu Vaccine Production (K Units) by Types 2021-2026
Figure Europe Flu Vaccine Production Market Share (%) by Types in 2020
Figure Europe Flu Vaccine Production Market Share (%) by Types in 2025
Table Whole Virus Vaccines Production (K Units) and Growth Rate
Table Whole Virus Vaccines Revenue (M USD) and Growth Rate
Table Split Virus Vaccines Production (K Units) and Growth Rate
Table Split Virus Vaccines Revenue (M USD) and Growth Rate
Table Subunit Vaccines Production (K Units) and Growth Rate
Table Subunit Vaccines Revenue (M USD) and Growth Rate
Table Live Attenuated Virus Vaccines Production (K Units) and Growth Rate
Table Live Attenuated Virus Vaccines Revenue (M USD) and Growth Rate
Table Europe 2021-2026 Flu Vaccine Sales by Application
Figure Europe Flu Vaccine Sales Market Share (%) by Application in 2020
Figure Europe Flu Vaccine Sales Market Share (%) by Application in 2025
Figure For Children (6 months to 3 years) Sales and Growth Rate 2021-2026
Figure For Adults and Children over 3 years Sales and Growth Rate 2021-2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Flu Vaccine Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Whole Virus Vaccines Market Performance (Volume)
2.1.2 Split Virus Vaccines Market Performance (Volume)
2.1.3 Subunit Vaccines Market Performance (Volume)
2.1.4 Live Attenuated Virus Vaccines Market Performance (Volume)
2.2 Overall Market Performance(Value)
2.2.1 Whole Virus Vaccines Market Performance (Value)
2.2.2 Split Virus Vaccines Market Performance (Value)
2.2.3 Subunit Vaccines Market Performance (Value)
2.2.4 Live Attenuated Virus Vaccines Market Performance (Value)
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 For Children (6 months to 3 years) Market Performance (Volume)
3.1.2 For Adults and Children over 3 years Market Performance (Volume)
4 Manufacturers Profiles/Analysis
4.1 CSL
4.1.1 CSL Profiles
4.1.2 CSL Product Information
4.1.3 CSL Flu Vaccine Business Performance
4.1.4 CSL Flu Vaccine Business Development and Market Status
4.2 GSK
4.2.1 GSK Profiles
4.2.2 GSK Product Information
4.2.3 GSK Flu Vaccine Business Performance
4.2.4 GSK Flu Vaccine Business Development and Market Status
4.3 Sanofi Pasteur
4.3.1 Sanofi Pasteur Profiles
4.3.2 Sanofi Pasteur Product Information
4.3.3 Sanofi Pasteur Flu Vaccine Business Performance
4.3.4 Sanofi Pasteur Flu Vaccine Business Development and Market Status
4.4 Mylan
4.4.1 Mylan Profiles
4.4.2 Mylan Product Information
4.4.3 Mylan Flu Vaccine Business Performance
4.4.4 Mylan Flu Vaccine Business Development and Market Status
4.5 AstraZeneca
4.5.1 AstraZeneca Profiles
4.5.2 AstraZeneca Product Information
4.5.3 AstraZeneca Flu Vaccine Business Performance
4.5.4 AstraZeneca Flu Vaccine Business Development and Market Status
4.6 Pfizer
4.6.1 Pfizer Profiles
4.6.2 Pfizer Product Information
4.6.3 Pfizer Flu Vaccine Business Performance
4.6.4 Pfizer Flu Vaccine Business Development and Market Status
4.7 Johnson & Johnson
4.7.1 Johnson & Johnson Profiles
4.7.2 Johnson & Johnson Product Information
4.7.3 Johnson & Johnson Flu Vaccine Business Performance
4.7.4 Johnson & Johnson Flu Vaccine Business Development and Market Status
5 Market Performance for Manufacturers
5.1 Europe Flu Vaccine Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Europe Flu Vaccine Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Europe Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
5.4 Europe Flu Vaccine Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 Germany Market Performance for Manufacturers
6.1.1 Germany Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 Germany Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 Germany Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 Germany Flu Vaccine Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 UK Market Performance for Manufacturers
6.2.1 UK Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 UK Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 UK Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 UK Flu Vaccine Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 France Market Performance for Manufacturers
6.3.1 France Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 France Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 France Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 France Flu Vaccine Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Russia Market Performance for Manufacturers
6.4.1 Russia Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Russia Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Russia Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Russia Flu Vaccine Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Benelux Market Performance for Manufacturers
6.5.1 Benelux Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Benelux Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Benelux Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Benelux Flu Vaccine Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 Italy Market Performance for Manufacturers
6.6.1 Italy Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 Italy Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 Italy Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 Italy Flu Vaccine Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Spain Market Performance for Manufacturers
6.7.1 Spain Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Spain Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Spain Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Spain Flu Vaccine Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 Market Performance for Manufacturers
6.8.1 Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 Flu Vaccine Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Europe Flu Vaccine Market Performance (Sales Point)
7.1 Europe Flu Vaccine Sales (K Units) and Market Share by Regions 2014-2020
7.2 Europe Flu Vaccine Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Europe Flu Vaccine Price (USD/Unit) by Regions 2014-2020
7.4 Europe Flu Vaccine Gross Margin by Regions 2014-2020
8 Development Trend for Regions (Sales Point)
8.1 Europe Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
8.2 Germany Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
8.3 UK Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 France Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
8.5 Russia Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
8.6 Benelux Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
8.7 Italy Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
8.8 Spain Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 For Children (6 months to 3 years) Industry
11.2 For Adults and Children over 3 years Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Europe Flu Vaccine Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Europe Flu Vaccine Sales (K Units) and Growth Rate 2021-2026
12.1.3 Germany Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 UK Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 France Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Russia Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Benelux Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 Italy Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Spain Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Whole Virus Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.3 Split Virus Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.4 Subunit Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.5 Live Attenuated Virus Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.3 Sales Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 For Children (6 months to 3 years) Sales and and Growth Rate 2021-2026
12.3.3 For Adults and Children over 3 years Sales and and Growth Rate 2021-2026
12.4 Price (USD/Unit) and Gross Profit Forecast
12.4.1 Europe Flu Vaccine Price (USD/Unit) Trend 2021-2026
12.4.2 Europe Flu Vaccine Gross Profit Trend 2021-2026
13 Conclusion
List of Tables and Figures
Figure Product Picture of Flu Vaccine
Table Product Specifications of Flu Vaccine
Table Manufacturers List in the Report
Table Manufacturers Production Market Share (%) 2014-2020
Table Regions Overview in 2019
Table Product Type and Standard
Table Type Overview in 2019
Table Product Application and Standard
Table Application Overview in 2019
Figure Industry Chain Structure of Flu Vaccine
Table Industry News List of Flu Vaccine
Figure New Project SWOT Analysis of Flu Vaccine
Table Europe Flu Vaccine Sales (K Units) by Types
Figure Europe Flu Vaccine Sales Market Share (%) by Types in 2014
Figure Europe Flu Vaccine Sales Market Share (%) by Types in 2019
Table Whole Virus Vaccines Sales (K Units) and Growth Rate
Figure Whole Virus Vaccines Sales (K Units) and Growth Rate
Table Split Virus Vaccines Sales (K Units) and Growth Rate
Figure Split Virus Vaccines Sales (K Units) and Growth Rate
Table Subunit Vaccines Sales (K Units) and Growth Rate
Figure Subunit Vaccines Sales (K Units) and Growth Rate
Table Live Attenuated Virus Vaccines Sales (K Units) and Growth Rate
Figure Live Attenuated Virus Vaccines Sales (K Units) and Growth Rate
Table Europe Flu Vaccine Revenue (M USD) by Types
Figure Europe Flu Vaccine Revenue Market Share (%) by Types in 2014
Figure Europe Flu Vaccine Revenue Market Share (%) by Types in 2019
Table Whole Virus Vaccines Revenue (M USD) and Growth Rate
Figure Whole Virus Vaccines Revenue (M USD) and Growth Rate
Table Split Virus Vaccines Revenue (M USD) and Growth Rate
Figure Split Virus Vaccines Revenue (M USD) and Growth Rate
Table Subunit Vaccines Revenue (M USD) and Growth Rate
Figure Subunit Vaccines Revenue (M USD) and Growth Rate
Table Live Attenuated Virus Vaccines Revenue (M USD) and Growth Rate
Figure Live Attenuated Virus Vaccines Revenue (M USD) and Growth Rate
Table Europe Flu Vaccine Sales (K Units) by Application 2014-2020
Figure Europe Flu Vaccine Sales Market Share (%) by Application in 2014
Figure Europe Flu Vaccine Sales Market Share (%) by Application in 2019
Table For Children (6 months to 3 years) Sales (K Units) and Growth Rate 2014-2020
Figure For Children (6 months to 3 years) Sales (K Units) and Growth Rate 2014-2020
Table For Adults and Children over 3 years Sales (K Units) and Growth Rate 2014-2020
Figure For Adults and Children over 3 years Sales (K Units) and Growth Rate 2014-2020
Table CSL Profiles
Table CSL Product Information
Table CSL Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table CSL Flu Vaccine Sales Change 2014-2020
Table CSL Flu Vaccine Market Status Change 2014-2020
Table GSK Profiles
Table GSK Product Information
Table GSK Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table GSK Flu Vaccine Sales Change 2014-2020
Table GSK Flu Vaccine Market Status Change 2014-2020
Table Sanofi Pasteur Profiles
Table Sanofi Pasteur Product Information
Table Sanofi Pasteur Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Sanofi Pasteur Flu Vaccine Sales Change 2014-2020
Table Sanofi Pasteur Flu Vaccine Market Status Change 2014-2020
Table Mylan Profiles
Table Mylan Product Information
Table Mylan Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Mylan Flu Vaccine Sales Change 2014-2020
Table Mylan Flu Vaccine Market Status Change 2014-2020
Table AstraZeneca Profiles
Table AstraZeneca Product Information
Table AstraZeneca Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table AstraZeneca Flu Vaccine Sales Change 2014-2020
Table AstraZeneca Flu Vaccine Market Status Change 2014-2020
Table Pfizer Profiles
Table Pfizer Product Information
Table Pfizer Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Pfizer Flu Vaccine Sales Change 2014-2020
Table Pfizer Flu Vaccine Market Status Change 2014-2020
Table Johnson & Johnson Profiles
Table Johnson & Johnson Product Information
Table Johnson & Johnson Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Johnson & Johnson Flu Vaccine Sales Change 2014-2020
Table Johnson & Johnson Flu Vaccine Market Status Change 2014-2020
Table Europe Flu Vaccine Sales (K Units) of Manufacturers 2014-2020
Table Europe Flu Vaccine Sales Market Share (%) of Manufacturers 2014-2020
Figure Europe Flu Vaccine Sales Market Share (%) in 2014
Figure Europe Flu Vaccine Sales Market Share (%) in 2019
Table Europe Flu Vaccine Revenue (M USD) of Manufacturers 2014-2020
Table Europe Flu Vaccine Revenue Market Share (%) of Manufacturers 2014-2020
Figure Europe Flu Vaccine Revenue Market Share (%) in 2014
Figure Europe Flu Vaccine Revenue Market Share (%) in 2019
Table Europe Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
Figure Europe Flu Vaccine Price (USD/Unit) of Manufacturers in 2014
Figure Europe Flu Vaccine Price (USD/Unit) of Manufacturers in 2019
Table Europe Flu Vaccine Gross Margin of Manufacturers 2014-2020
Figure Europe Flu Vaccine Gross Margin of Manufacturers in 2014
Figure Europe Flu Vaccine Gross Margin in 2019
Figure Europe Flu Vaccine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table UK Flu Vaccine Sales (K Units) of Manufacturers 2014-2020
Table UK Flu Vaccine Sales Market Share (%) of Manufacturers 2014-2020
Figure UK Flu Vaccine Sales Market Share (%) in 2014
Figure UK Flu Vaccine Sales Market Share (%) in 2019
Table UK Flu Vaccine Revenue (M USD) of Manufacturers 2014-2020
Table UK Flu Vaccine Revenue Market Share (%) of Manufacturers 2014-2020
Figure UK Flu Vaccine Revenue Market Share (%) in 2014
Figure UK Flu Vaccine Revenue Market Share (%) in 2019
Table UK Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
Figure UK Flu Vaccine Price (USD/Unit) of Manufacturers in 2014
Figure UK Flu Vaccine Price (USD/Unit) of Manufacturers in 2019
Table UK Flu Vaccine Gross Margin of Manufacturers 2014-2020
Figure UK Flu Vaccine Gross Margin of Manufacturers in 2014
Figure UK Flu Vaccine Gross Margin in 2019
Figure UK Flu Vaccine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table France Flu Vaccine Sales (K Units) of Manufacturers 2014-2020
Table France Flu Vaccine Sales Market Share (%) of Manufacturers 2014-2020
Figure France Flu Vaccine Sales Market Share (%) in 2014
Figure France Flu Vaccine Sales Market Share (%) in 2019
Table France Flu Vaccine Revenue (M USD) of Manufacturers 2014-2020
Table France Flu Vaccine Revenue Market Share (%) of Manufacturers 2014-2020
Figure France Flu Vaccine Revenue Market Share (%) in 2014
Figure France Flu Vaccine Revenue Market Share (%) in 2019
Table France Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
Figure France Flu Vaccine Price (USD/Unit) of Manufacturers in 2014
Figure France Flu Vaccine Price (USD/Unit) of Manufacturers in 2019
Table France Flu Vaccine Gross Margin of Manufacturers 2014-2020
Figure France Flu Vaccine Gross Margin of Manufacturers in 2014
Figure France Flu Vaccine Gross Margin in 2019
Figure France Flu Vaccine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Russia Flu Vaccine Sales (K Units) of Manufacturers 2014-2020
Table Russia Flu Vaccine Sales Market Share (%) of Manufacturers 2014-2020
Figure Russia Flu Vaccine Sales Market Share (%) in 2014
Figure Russia Flu Vaccine Sales Market Share (%) in 2019
Table Russia Flu Vaccine Revenue (M USD) of Manufacturers 2014-2020
Table Russia Flu Vaccine Revenue Market Share (%) of Manufacturers 2014-2020
Figure Russia Flu Vaccine Revenue Market Share (%) in 2014
Figure Russia Flu Vaccine Revenue Market Share (%) in 2019
Table Russia Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
Figure Russia Flu Vaccine Price (USD/Unit) of Manufacturers in 2014
Figure Russia Flu Vaccine Price (USD/Unit) of Manufacturers in 2019
Table Russia Flu Vaccine Gross Margin of Manufacturers 2014-2020
Figure Russia Flu Vaccine Gross Margin of Manufacturers in 2014
Figure Russia Flu Vaccine Gross Margin in 2019
Figure Russia Flu Vaccine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Benelux Flu Vaccine Sales (K Units) of Manufacturers 2014-2020
Table Benelux Flu Vaccine Sales Market Share (%) of Manufacturers 2014-2020
Figure Benelux Flu Vaccine Sales Market Share (%) in 2014
Figure Benelux Flu Vaccine Sales Market Share (%) in 2019
Table Benelux Flu Vaccine Revenue (M USD) of Manufacturers 2014-2020
Table Benelux Flu Vaccine Revenue Market Share (%) of Manufacturers 2014-2020
Figure Benelux Flu Vaccine Revenue Market Share (%) in 2014
Figure Benelux Flu Vaccine Revenue Market Share (%) in 2019
Table Benelux Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
Figure Benelux Flu Vaccine Price (USD/Unit) of Manufacturers in 2014
Figure Benelux Flu Vaccine Price (USD/Unit) of Manufacturers in 2019
Table Benelux Flu Vaccine Gross Margin of Manufacturers 2014-2020
Figure Benelux Flu Vaccine Gross Margin of Manufacturers in 2014
Figure Benelux Flu Vaccine Gross Margin in 2019
Figure Benelux Flu Vaccine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Italy Flu Vaccine Sales (K Units) of Manufacturers 2014-2020
Table Italy Flu Vaccine Sales Market Share (%) of Manufacturers 2014-2020
Figure Italy Flu Vaccine Sales Market Share (%) in 2014
Figure Italy Flu Vaccine Sales Market Share (%) in 2019
Table Italy Flu Vaccine Revenue (M USD) of Manufacturers 2014-2020
Table Italy Flu Vaccine Revenue Market Share (%) of Manufacturers 2014-2020
Figure Italy Flu Vaccine Revenue Market Share (%) in 2014
Figure Italy Flu Vaccine Revenue Market Share (%) in 2019
Table Italy Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
Figure Italy Flu Vaccine Price (USD/Unit) of Manufacturers in 2014
Figure Italy Flu Vaccine Price (USD/Unit) of Manufacturers in 2019
Table Italy Flu Vaccine Gross Margin of Manufacturers 2014-2020
Figure Italy Flu Vaccine Gross Margin of Manufacturers in 2014
Figure Italy Flu Vaccine Gross Margin in 2019
Figure Italy Flu Vaccine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Spain Flu Vaccine Sales (K Units) of Manufacturers 2014-2020
Table Spain Flu Vaccine Sales Market Share (%) of Manufacturers 2014-2020
Figure Spain Flu Vaccine Sales Market Share (%) in 2014
Figure Spain Flu Vaccine Sales Market Share (%) in 2019
Table Spain Flu Vaccine Revenue (M USD) of Manufacturers 2014-2020
Table Spain Flu Vaccine Revenue Market Share (%) of Manufacturers 2014-2020
Figure Spain Flu Vaccine Revenue Market Share (%) in 2014
Figure Spain Flu Vaccine Revenue Market Share (%) in 2019
Table Spain Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
Figure Spain Flu Vaccine Price (USD/Unit) of Manufacturers in 2014
Figure Spain Flu Vaccine Price (USD/Unit) of Manufacturers in 2019
Table Spain Flu Vaccine Gross Margin of Manufacturers 2014-2020
Figure Spain Flu Vaccine Gross Margin of Manufacturers in 2014
Figure Spain Flu Vaccine Gross Margin in 2019
Figure Spain Flu Vaccine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Flu Vaccine Sales (K Units) of Manufacturers 2014-2020
Table Flu Vaccine Sales Market Share (%) of Manufacturers 2014-2020
Figure Flu Vaccine Sales Market Share (%) in 2014
Figure Flu Vaccine Sales Market Share (%) in 2019
Table Flu Vaccine Revenue (M USD) of Manufacturers 2014-2020
Table Flu Vaccine Revenue Market Share (%) of Manufacturers 2014-2020
Figure Flu Vaccine Revenue Market Share (%) in 2014
Figure Flu Vaccine Revenue Market Share (%) in 2019
Table Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
Figure Flu Vaccine Price (USD/Unit) of Manufacturers in 2014
Figure Flu Vaccine Price (USD/Unit) of Manufacturers in 2019
Table Flu Vaccine Gross Margin of Manufacturers 2014-2020
Figure Flu Vaccine Gross Margin of Manufacturers in 2014
Figure Flu Vaccine Gross Margin in 2019
Figure Flu Vaccine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Europe Flu Vaccine Sales (K Units) by Regions 2014-2020
Table Europe Flu Vaccine Sales Market Share (%) by Regions 2014-2020
Figure Europe Flu Vaccine Sales Market Share (%) by Regions in 2014
Figure Europe Flu Vaccine Sales Market Share (%) by Regions in 2019
Table Europe Flu Vaccine Revenue (M USD) by Regions 2014-2020
Table Europe Flu Vaccine Revenue Market Share (%) by Regions 2014-2020
Figure Europe Flu Vaccine Revenue Market Share (%) by Regions in 2014
Figure Europe Flu Vaccine Revenue Market Share (%) by Regions in 2019
Table Europe Flu Vaccine Price (USD/Unit) by Regions 2014-2020
Figure Europe Flu Vaccine Price (USD/Unit) by Regions in 2014
Figure Europe Flu Vaccine Price (USD/Unit) by Regions in 2019
Table Europe Flu Vaccine Gross Margin by Regions 2014-2020
Figure Europe Flu Vaccine Gross Margin by Regions in 2014
Figure Europe Flu Vaccine Gross Margin by Regions in 2019
Figure Europe Flu Vaccine Sales (K Units) and Growth Rate 2014-2020
Figure Europe Flu Vaccine Revenue (M USD) and Growth Rate 2014-2020
Figure Germany Flu Vaccine Sales (K Units) and Growth Rate 2014-2020
Figure Germany Flu Vaccine Revenue (M USD) and Growth Rate 2014-2020
Figure UK Flu Vaccine Sales (K Units) and Growth Rate 2014-2020
Figure UK Flu Vaccine Revenue (M USD) and Growth Rate 2014-2020
Figure France Flu Vaccine Sales (K Units) and Growth Rate 2014-2020
Figure France Flu Vaccine Revenue (M USD) and Growth Rate 2014-2020
Figure Russia Flu Vaccine Sales (K Units) and Growth Rate 2014-2020
Figure Russia Flu Vaccine Revenue (M USD) and Growth Rate 2014-2020
Figure Benelux Flu Vaccine Sales (K Units) and Growth Rate 2014-2020
Figure Benelux Flu Vaccine Revenue (M USD) and Growth Rate 2014-2020
Figure Italy Flu Vaccine Sales (K Units) and Growth Rate 2014-2020
Figure Italy Flu Vaccine Revenue (M USD) and Growth Rate 2014-2020
Figure Spain Flu Vaccine Sales (K Units) and Growth Rate 2014-2020
Figure Spain Flu Vaccine Revenue (M USD) and Growth Rate 2014-2020
Figure Flu Vaccine Sales (K Units) and Growth Rate 2014-2020
Figure Flu Vaccine Revenue (M USD) and Growth Rate 2014-2020
Table Upstream Source for Manufacturers
Table Manufacture Technology of Flu Vaccine
Figure Cost Structure of Flu Vaccine in 2019
Table Europe Flu Vaccine Production (K Units) by Regions 2021-2026
Table Europe Flu Vaccine Production Market Share (%) by Regions 2021-2026
Figure Europe Flu Vaccine Production Market Share (%) by Regions in 2019
Figure Europe Flu Vaccine Production Market Share (%) by Regions in 2024
Table Europe Flu Vaccine Revenue (M USD) by Regions 2021-2026
Table Europe Flu Vaccine Revenue Market Share (%) by Regions 2021-2026
Figure Europe Flu Vaccine Revenue Market Share (%) by Regions in 2019
Figure Europe Flu Vaccine Revenue Market Share (%) by Regions in 2024
Figure Europe Flu Vaccine Production (K Units) and Growth Rate 2021-2026
Figure Europe Flu Vaccine Revenue (M USD) and Growth Rate 2021-2026
Figure Germany Flu Vaccine Production (K Units) and Growth Rate 2021-2026
Figure Germany Flu Vaccine Revenue (M USD) and Growth Rate 2021-2026
Figure UK Flu Vaccine Production (K Units) and Growth Rate 2021-2026
Figure UK Flu Vaccine Revenue (M USD) and Growth Rate 2021-2026
Figure France Flu Vaccine Production (K Units) and Growth Rate 2021-2026
Figure France Flu Vaccine Revenue (M USD) and Growth Rate 2021-2026
Figure Russia Flu Vaccine Production (K Units) and Growth Rate 2021-2026
Figure Russia Flu Vaccine Revenue (M USD) and Growth Rate 2021-2026
Figure Benelux Flu Vaccine Production (K Units) and Growth Rate 2021-2026
Figure Benelux Flu Vaccine Revenue (M USD) and Growth Rate 2021-2026
Figure Italy Flu Vaccine Production (K Units) and Growth Rate 2021-2026
Figure Italy Flu Vaccine Revenue (M USD) and Growth Rate 2021-2026
Figure Spain Flu Vaccine Production (K Units) and Growth Rate 2021-2026
Figure Spain Flu Vaccine Revenue (M USD) and Growth Rate 2021-2026
Figure Flu Vaccine Production (K Units) and Growth Rate 2021-2026
Figure Flu Vaccine Revenue (M USD) and Growth Rate 2021-2026
Table Europe Flu Vaccine Production (K Units) by Types 2021-2026
Figure Europe Flu Vaccine Production Market Share (%) by Types in 2020
Figure Europe Flu Vaccine Production Market Share (%) by Types in 2025
Table Whole Virus Vaccines Production (K Units) and Growth Rate
Table Whole Virus Vaccines Revenue (M USD) and Growth Rate
Table Split Virus Vaccines Production (K Units) and Growth Rate
Table Split Virus Vaccines Revenue (M USD) and Growth Rate
Table Subunit Vaccines Production (K Units) and Growth Rate
Table Subunit Vaccines Revenue (M USD) and Growth Rate
Table Live Attenuated Virus Vaccines Production (K Units) and Growth Rate
Table Live Attenuated Virus Vaccines Revenue (M USD) and Growth Rate
Table Europe 2021-2026 Flu Vaccine Sales by Application
Figure Europe Flu Vaccine Sales Market Share (%) by Application in 2020
Figure Europe Flu Vaccine Sales Market Share (%) by Application in 2025
Figure For Children (6 months to 3 years) Sales and Growth Rate 2021-2026
Figure For Adults and Children over 3 years Sales and Growth Rate 2021-2026
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now let’s take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.
You can also purchase parts of this report. Do you want to check out a section wise price list?
Personalized Business Report Tailored to Your Requirements
- Our expert analysts collaborate directly with you to comprehend your specific needs.
- Get data on regions, segments, competitors, and vendors of your choice.
- Information is presented in alignment with your exact preferences and formatting.
Free Sample Report
"Find new revenue generation opportunities"